Francis Victor | Nanotechnology in Food Science | Innovative Research Award

Posted on by Food Scientist

Innovative Research Award

Francis Victor
Affiliation Punjab Forensic Science Agency, Lahore
Country Pakistan
Scopus ID 57219513484
Documents 6
Citations 88
h-index 3
Subject Area Nanotechnology in Food Science Award
Event International Food Scientist Awards
ORCID 0009-0005-3315-3665

Francis Victor
Punjab Forensic Science Agency, Lahore, Pakistan

Francis Victor is a researcher affiliated with the Punjab Forensic Science Agency, Lahore. His published work spans pharmaceutical sciences, nanotechnology, drug delivery systems, molecular biology, and biomedical research. His scholarly interests include advanced therapeutic technologies, personalized medicine, polymeric nanocarriers, molecular genetics, and translational healthcare applications. According to publicly available Scopus metrics, his research profile comprises 6 indexed publications, 88 citations, and an h-index of 3, demonstrating emerging scholarly contributions within interdisciplinary biomedical and nanotechnology research.[1]

Abstract

This article presents an academic overview of Francis Victor and his scientific contributions. His publications focus on personalized medicine, pharmaceutical compounding, nanotechnology-based drug delivery systems, molecular genetics, and biomedical applications. These interdisciplinary investigations contribute to the development of advanced therapeutic strategies, precision healthcare, and innovative pharmaceutical technologies while demonstrating the integration of molecular science with applied clinical research.[2]

Keywords

Nanotechnology, Drug Delivery Systems, Personalized Medicine, Biomedical Engineering, Pharmaceutical Sciences, Molecular Biology, Polymeric Nanocarriers, Precision Therapeutics

Introduction

Modern biomedical research increasingly relies upon nanotechnology, pharmaceutical engineering, and molecular diagnostics to improve therapeutic outcomes. Francis Victor’s publications address several of these emerging areas through investigations into personalized oncology, polymer-based drug delivery systems, and genetic biomarkers. His work reflects interdisciplinary collaboration across pharmaceutical sciences and biomedical research.[1]

Research Profile

Francis Victor’s research profile encompasses pharmaceutical nanotechnology, personalized medicine, molecular genetics, drug formulation, polymer science, precision therapeutics, and translational biomedical research. His scientific publications demonstrate an interest in developing innovative therapeutic platforms while investigating molecular mechanisms associated with human disease. His work combines experimental laboratory methods with clinical and pharmaceutical applications.[1]

Research Contributions

  • Research on pharmaceutical compounding for personalized oncology treatments.
  • Development and evaluation of polymersome-based drug delivery technologies.
  • Investigation of FOXP3 genetic polymorphisms in relation to disease biomarkers.
  • Application of nanotechnology to advanced pharmaceutical formulations.
  • Contribution to interdisciplinary biomedical and molecular research.

Publications

  1. Pharmaceutical Compounding as a Pillar of Personalized Oncology: Current Applications, Emerging Technologies, and Future Perspectives. Pharmaceuticals (2026). DOI:
    10.3390/ph19071077.
  2. Biochemical Investigation of FOXP3 Genetic Polymorphism and Its Association with Biochemical Parameters in Pre-Eclampsia Patients. Naunyn-Schmiedeberg’s Archives of Pharmacology (2024). DOI:
    10.1007/s00210-024-03580-z.
  3. Polymersomes as the Next Attractive Generation of Drug Delivery Systems: Definition, Synthesis and Applications. Materials (2024). DOI:
    10.3390/ma17020319.

Research Impact

Available bibliometric indicators indicate developing academic visibility within pharmaceutical sciences and nanotechnology research. Although representing an early-stage publication portfolio, the available citation record demonstrates that the published studies have attracted measurable scholarly attention. His interdisciplinary research themes remain relevant to current developments in precision medicine, advanced drug delivery, and pharmaceutical innovation.[1]

Award Suitability

Based on the available publication record, research scope, and bibliometric indicators, Francis Victor has contributed to interdisciplinary areas involving nanotechnology, pharmaceutical sciences, and biomedical innovation. His published work on drug delivery systems, personalized oncology, and molecular biology aligns with emerging technologies that intersect with advanced food, pharmaceutical, and nanoscience applications. These contributions support consideration for recognition within innovation-focused scientific award programs.[1]

Conclusion

Francis Victor has established an emerging research profile through interdisciplinary investigations in pharmaceutical sciences, nanotechnology, molecular biology, and precision medicine. His publications contribute to the understanding of innovative therapeutic technologies and advanced drug delivery systems while reflecting continued engagement with contemporary biomedical research challenges. His work represents a developing contribution to translational scientific research.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Francis Victor, Author ID 57219513484. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57219513484
  2. Pharmaceutical Compounding as a Pillar of Personalized Oncology: Current Applications, Emerging Technologies, and Future Perspectives. Pharmaceuticals (2026). https://doi.org/10.3390/ph19071077
  3. Biochemical Investigation of FOXP3 Genetic Polymorphism and Its Association with Biochemical Parameters in Pre-Eclampsia Patients. Naunyn-Schmiedeberg’s Archives of Pharmacology (2024). https://doi.org/10.1007/s00210-024-03580-z
  4. Polymersomes as the Next Attractive Generation of Drug Delivery Systems: Definition, Synthesis and Applications. Materials (2024).
    https://doi.org/10.3390/ma17020319

Vikram Kumar | Nutraceuticals | Best Researcher Award

Posted on by Food Scientist

Best Researcher Award

Vikram Kumar
Affiliation Amity University Rajasthan
Country India
Scopus ID 57188881962
Documents 45
Citations 420
h-index 10
Subject Area Functional Ingredients and Nutraceuticals
Event International Food Scientist Awards
ORCID 0000-0002-9994-8904

Vikram Kumar
Amity University Rajasthan, India

Vikram Kumar is an Indian pharmaceutical scientist, academic researcher, educator, and doctoral supervisor serving as Associate Professor and PhD Coordinator at Amity Institute of Pharmacy, Amity University Rajasthan, Jaipur. With over sixteen years of teaching, research, and academic administration experience, he has contributed extensively to pharmacology, nanotechnology-based drug delivery systems, herbal therapeutics, cancer research, and pharmaceutical education. His scholarly output includes peer-reviewed publications, patents, book chapters, funded research projects, doctoral supervision, and editorial responsibilities in national and international scientific journals.[1]

Abstract

This academic profile presents the scholarly achievements, research contributions, academic leadership, and professional impact of Dr. Vikram Kumar. His work spans pharmaceutical sciences, pharmacology, herbal medicine, nanomedicine, cancer biology, neuropharmacology, and pharmaceutical education. Through publications, patents, funded projects, doctoral supervision, editorial service, and institutional leadership, he has contributed to both scientific advancement and academic capacity building within higher education institutions.[1]

Keywords

Pharmacology, Pharmaceutical Sciences, Drug Delivery Systems, Nanotechnology, Herbal Medicine, Cancer Research, Pharmaceutical Education, Pharmacogenomics, Neuroprotection, Academic Leadership.

Introduction

Vikram Kumar completed his Bachelor of Pharmacy, Master of Pharmacy in Pharmacology, and Doctor of Philosophy in Pharmacology. His academic career includes appointments at Sri Balaji College of Pharmacy, Bahra University, and Amity University Rajasthan. Throughout his professional journey, he has combined teaching excellence with active research engagement and academic administration responsibilities. His multidisciplinary expertise has enabled collaborations across pharmaceutical sciences, biotechnology, and translational research domains.[1]

Research Profile

  • Associate Professor and PhD Coordinator, Amity Institute of Pharmacy.
  • Scopus Author ID: 57188881962.
  • ORCID: 0000-0002-9994-8904.
  • Approximate cumulative journal impact factor exceeding 122.
  • Reviewer and editorial board member for several international journals.
  • Principal investigator and collaborator in government-funded research projects.

Research Contributions

Kumar’s research portfolio encompasses nanostructured lipid carriers, nanoemulsion-based therapeutics, herbal formulations, pharmacogenomics, antimicrobial technologies, anti-inflammatory agents, neuroprotective interventions, and breast cancer therapeutics. His funded projects supported by the Department of Science and Technology, Government of Rajasthan, focused on antimicrobial nanotechnology and silver nanoparticle synthesis using plant-derived materials.[2]

Publications

Kumar has authored and co-authored research articles, books, and book chapters in reputable scientific outlets. Representative contributions include investigations into anti-inflammatory activity, anti-nociceptive pharmacology, pharmacogenomics, breast cancer susceptibility, nanoplastic toxicity, and emerging therapeutic technologies.[4]

  • 72+ peer-reviewed research publications.
  • 4 published book chapters with international publishers.
  • Author of a pharmacology textbook.
  • 17 first-author publications.
  • 31 corresponding-author publications.

Research Impact

The impact of Kumar’s work is reflected through scientific publications, citation metrics, funded projects, doctoral mentorship, and intellectual property achievements. His research has contributed to contemporary discussions in pharmaceutical technology, targeted drug delivery, phytomedicine, and biomedical innovation. The grant of international and national patents further illustrates the translational relevance of his scientific activities.[5]

Award Suitability

Based on documented evidence of scholarly productivity, research leadership, academic administration, intellectual property generation, doctoral supervision, professional memberships, and sustained contributions to pharmaceutical sciences, Dr. Vikram Kumar demonstrates attributes commonly associated with recipients of academic research excellence recognitions. His interdisciplinary research profile and continued engagement in innovation-oriented pharmaceutical research support consideration for an Outstanding Researcher Award.[5]

Conclusion

Vikram Kumar has established a comprehensive academic and research profile characterized by sustained contributions to pharmacology, pharmaceutical sciences, research mentoring, innovation, and higher education leadership. His scholarly achievements, patents, publications, funded projects, and doctoral supervision collectively illustrate a notable commitment to advancing scientific knowledge and academic excellence.

References

  1. Amity University Rajasthan. (2026). Faculty Profile: Dr. Vikram Kumar, Associate Professor, Amity Institute of Pharmacy.
  2. ORCID. (2026). ORCID Record: Dr. Vikram Kumar (ORCID: 0000-0002-9994-8904).
    https://orcid.org/0000-0002-9994-8904
  3. Google Scholar. (2026). Google Scholar Profile of Dr. Vikram Kumar.
    https://scholar.google.com/citations?user=OJX4BywAAAAJ&hl=en
  4. Elsevier Scopus. (2026). Scopus Author Profile: Dr. Vikram Kumar, Author ID 57188881962.
    https://www.scopus.com/authid/detail.uri?authorId=57188881962
  5. Springer Nature. (2021). Impact of MicroRNA Polymorphisms on Breast Cancer Susceptibility.
    DOI: https://doi.org/10.1007/978-981-33-6699-